# Discure Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/discure-technologies

- Industry: Medical Devices & Equipment
- Headquarters: Petah Tikva, Israel
- Website: www.discuremd.com/
- Total disclosed funding: $11M
- Latest round: Series A (Sep 10, 2024)
- Investors on record: 3

## About

Based in Tel Aviv, Israel, and founded in 2021, Discure Technologies operates as a medical device company focused on treating and reversing degenerative disc disease through a bioelectronic, minimally invasive system. In September 2024, Discure Technologies raised USD 11 million in Series A funding co-led by BOLD Capital Partners, Supernova Invest, and Samara Capital. The firm’s partners include VTC Ventures, Johnson and Johnson, Sanara Capital, Rainbow Medical Innovation, etc.

The firm’s solution involves a minimally invasive, implantable bioelectronic device designed to reverse disc degeneration, restore disc health, and reduce pain without the need for hospitalization or rehab. Discure offers a disease-modifying approach aimed at reducing opioid use and avoiding invasive surgery. 

The company intends to use the September 2024 funding to expand operations and its development efforts.

## Funding rounds

- Series A, Sep 10, 2024, $11M — BOLD Capital Partners, Supernova Invest, Sanara Capital

## Investors

- BOLD Capital Partners (https://capitalatlas.ai/funds/bold-capital-partners) — Series A
- Supernova Invest (https://capitalatlas.ai/funds/supernova-invest) — Series A
- Sanara Capital (https://capitalatlas.ai/funds/sanara-capital) — Series A